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osting by EAbstract Purpose: This study was performed to evaluate the role of the chest radiography pul-
monary function tests, and HRCT in the early diagnosis of the emphysema.
Materials and methods: The study included 50 patients who had emphysema. Average age varies
between 40 and 60 years. All patients were subjected to full history, clinical examination, laboratory
investigations, cardiac investigations, chest radiography, pulmonary function tests and HRCT.
Results: I found high sensitivity of the HRCT in the early diagnosis of emphysema if compared
with sensitivity of the chest radiography and pulmonary function tests.
Conclusions: HRCT has much greater sensitivity than chest radiography in early diagnosing of
emphysema. HRCT is also capable of differentiating between the various types of emphysema
and assessing its severity. The presence of emphysema can be suspected on chest radiography but
this is not a sensitive technique for diagnosis. Also the chest radiography is not a very good indi-
cator for the severity of disease. In addition a precise characterization of the emphysema by HRCT
is desirable for adequate therapy and monitoring as well as preoperative assessment of the patient
before surgical treatment of emphysema. Compared to spirometry, HRCT shows regional assess-
ment of compartments involved (airways, parenchyma and vasculature). Moreover spirometry
has no deﬁnite sensitivity.
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Open access under 1. Introduction
Pulmonary emphysema is a pathological term and is deﬁned
by the American Thoracic Society as an abnormal permanent
enlargement of the air spaces distal to the terminal bronchiole,
accompanied by the destruction of their walls (42). In a simpli-
ﬁed way, obstructive air low limitation leads to air trapping
with subsequent hyperinﬂation and later destruction of the
lung parenchyma (1). Emphysema is one of the COPD. The
etiology of pulmonary emphysema has not been fully estab-
lished, but the prevailing concept is that lung inﬂammation
510 M.M.S. Mostafais caused by cigarette smoke, environmental pollutants, or bac-
terial products (2). The diagnosis of emphysema is convention-
ally based upon spirometry, but during the early stage of the
disease, conventional spirometry may reveal no abnormality
(3). In particular, HRCT is an available tool for demonstrating
the pathology of emphysema, even in subtle changes within
secondary pulmonary lobules (4).
2. Patients and methods
2.1. Patients
This study was performed at Chest and Radiology Depart-
ments, New Dammietta Hospital, Al Azhar University at the
period from December 2008 to February 2010. The study
was conducted on 50 patients (50 males). Their ages ranged
from 40 to 60 years presenting to the out patients clinic chest
department.
2.2. Methods
All the patients were subjected to the following:
(A) History including: Personal history, occupation and spe-
cial habits (smoking history was obtained and cumula-
tive pack years of exposure were calculated). History
of dyspnea that was irreversible air ﬂow limitation
(post-inhalation bronchodilator FEV1 less than 80%
of the predicted value in combination with FEV1/FVC
not more than 70% of the predicted value). They had
an increase in FEV1 less than 200 ml or less than 12%
of the baseline value 20 min after inhalation bronchodi-
lator in accordance with the GOLD guidelines.
(B) Exclusion criteria: Patients with one of the following cri-
teria were excluded from the study: the patients who had
bronchiectasis, cystic disease, TB, chest infection, bron-
chial asthma, interstitial lung disease, chest tumour, pre-
vious thoracotomy, coronary and cerebral diseases, as
well as patients with past history of DM, sarcoidosis
and uremia.
(C) Clinical examination: General and local examinations.
(D) Laboratory investigations: Routine laboratory investiga-
tions as CBC, blood sugar, liver and renal functions tests.
(E) Cardiac investigations: ECG and echocardiography.
(F) Chest radiography: Posterior anterior and left lateral
views.
(G) Pulmonary function tests: We do pulmonary function
tests before and 20 min after inhalation of bronchodila-
tor (three trials were done and the best were taken)and
the following data recorded:
 Forced expiratory volume in the ﬁrst second (FEV1)
in liters/second.
 Forced vital capacity (FVC) in liters/second.
 Forced expiratory volume in the ﬁrst second/forced
vital capacity% (FEV1/FVC%).(H) High resolution CT:
 All scans were obtained by using a CT Hi speed
advantage scanner (SIEMENS) Somatom. HRCT
scanning without contrast was done at full inspira-
tion with 1 mm collimation at (120 KVP, 200 MAS),matrix size of 512 · 512, scans were taken at 10 mm
interval with window setting appropriate for the lungs
(widow level from 700 to 900 HU, width from 800
to1000 HU).The following features were evaluated using HRCT:
1. Tracheal index: A ration of transverse to antero-
posterior diameter at a plane 1 cm above the aortic
arch. Saber sheath trachea was described as when
the tracheal index was less than 2/3.
2. Thoracic cage ratio: A ration antero-posterior to
transverse diameter. It was evaluated at two planes:
(A) carina and (B) 5 cm below carina.
3. Sterno-aortic distance: Distance from posterior sur-
face of the sternum to anterior margin of the aortic
at carinal level.
4. Thoracic cross sectional area: Thoracic cross sec-
tional area was measured on HRCT images made
1 cm below the top of aortic arch. The ratio of TCSA
to the square of height (TCSA/height2) was calcu-
lated for each patient.
5. Vascular attenuation: Vascular attenuation was con-
sidered when there was thinning of pulmonary ves-
sels and reduction in their number.
6. Vascular distortion: Vascular distortion was consid-
ered as increased angles and/or excessive straighten-
ing of pulmonary vessels.
7. Mosaic attenuation pattern: Mosaic attenuation
mean non homogenous lung density, the latter was
described as areas that remain relatively lucent inter-
spersed with areas of normal or higher lung density.
8. Direct visible small airways: The airways with inter-
nal diameter not more than 2 mm.
3. Results
This study includes 50 patients of emphysema. There were 50
males. The patients characteristics were as shown in Table 1.
Their age ranged from 40 to 60 years (mean 52.34 ± 633).
The duration of the disease ranged from 3 to 23 years (mean
18.76 ± 5.49). The dyspnea scale ranged from 1 to 5 years
(mean 2.78 ± 1.282). The smoking pack years ranged from
10 to 50 years (mean 35 ± 14.743). Table 1 also shows the
quantitative HRCT features. The tracheal index (1 cm above
aortic arch) ranged from 0.45 to 0.93 (mean 0.696 ± 0.143).
The thoracic cage ratio at carina ranged from 62.15 to 79.12
(mean 70.657 ± 6.58). The thoracic cage ratio at 5 cm below
carina ranged from 63.8 to 85.1 (mean 73.988 ± 7.773). The
sterno aortic distance at carinal level (cm) ranged from 1.45
to 4.9 (mean 3.898 ± 0.9507). The thoracic cross sectional area
1 cm below the top of aortic arch ranged from 62.1 to 105.1
(mean 89.272 ± 14.423). The lung function tests are shown
in Table 2. The baseline FEVI ranged from 0.4 to 10.3 l/s
(mean 2.3339 ± 2.455) pre-inhalation bronchodilator and ran-
ged from 0.5 to 5.1 l/s (mean 1.926 ± 1.317) post-inhalation
bronchodilator. The baseline FVC ranged from 1 to 6.1 l/s
(mean 2.570 ± 1.357) pre-inhalation bronchodilator and ran-
ged from 1 to 6.3 (mean 2.784 ± 1.319) post-inhalation bron-
chodilator. The baseline FEVI/FVC ratio ranged from 38% to
Table 1 Patient characteristics (No. of patients 50).
Parameter Minimum Maximum Mean SD
Age in years 40 60 52.34 6.33
Duration of disease 3 23 18.76 5.49
Dyspnea scale 1 5 2.78 1.282
Pack years of cigarette smoking 10 50 35 14.743
Tracheal index (1 cm above aortic arch) 0.45 0.93 0.696 0.143
Thoracic cage ratio at carina 62.15 79.12 70.657 6.58
Thoracic cage ratio at 5 cm below carina 63.8 85.1 73.988 7.773
Sterno aortic distance at carinal level (cm) 1.45 4.9 3.898 0.9507
Thoracic cross sectional area 1 cm below the top of aortic arch 62.1 105.1 89.272 14.423
Table 2 Pulmonary function tests (No. of patients 50).
Baseline FEV1 L/S Paired t-test
Range Mean ± SD t P-value
FEV1 L/S
Pre-inhalation bronchodilator 0.4–10.3 2.339 ± 2.455
Post-inhalation bronchodilator 0.5–5.1 1.926 ± 1.317 1.332 0.189
Predicted FEV1 L/S
Pre-inhalation bronchodilator 16.0–119.0 53.400 ± 29.107
Post-inhalation bronchodilator 20.0–120.0 58.540 ± 28.414 9.416 0.000
FVC L/S Baseline FVC L/S
Pre-inhalation bronchodilator 1.0–6.1 2.570 ± 1.357
Post-inhalation bronchodilator 1.0–6.3 2.784 ± 1.319 8.359 0.000
Predicted FVC L/S
Pre-inhalation bronchodilator 30.0–115.0 62.880 ± 21.473
Post-inhalation bronchodilator 39.0–118.0 68.940 ± 19.999 8.441 0.000
FEV1/FVC% Baseline FEV1/FVC%
Pre-inhalation bronchodilator 38.0–88.0 63.300 ± 13.737
Post-inhalation bronchodilator 47.0–90.0 66.864 ± 11.722 5.824 0.000
Table 3 HRCT features in individual patients (No. of patients
50).
HRCT features No. of
patients
Percentage
of patients (%)
Tracheal index <0.67 27 54
Thoracic cage ratio at carina
>0.75
22 44
Thoracic cage ratio at 5 cm below
carina >0.75
27 54
Sterno aortic distance 64 cm 33 66
Thoracic cross sectional area/
height2 > 80 cm2/m2
38 76
Vascular attenuation 27 54
Vascular distortion 10 20
Mosaic attenuation pattern 18 36
Directly visible small airways 38 76
Centriacinar emphysema 16 32
Panacinar emphysema 10 20
Distal acinar emphysema 7 14
All types of emphysema 17 34
Associated chronic bronchitis 15 30
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ranged from 47% to 90% (mean 66.864 ± 11.722) post-inha-
lation bronchodilator. In our study the sensitivity of the chest
radiography in the early diagnosis of the emphysema was 40%.
In our study the sensitivity of the spirometry in early diagnosis
of the emphysema was 80%. In our study the sensitivity of the
HRCT in early diagnosis of the emphysema was 100%.
The HRCT features in individual patients were as shown in
(Table 3). The tracheal index was less than 0.67% and was
found in 27 patients (54%). Abnormal thoracic cage ratio
was more common at 5 cm below carina and was found in
27 patients (54%) than at carina in 22 patients (44%). Sterno
aortic distance 4 cm or more was found in 33 patients (66%).
A large ratio of thoracic cross sectional area/height2 was pre-
sented in 38 patients (76%). Direct visible small airways was
the most common ﬁnding that was presented in 38 patients
(76%) followed by vascular attenuation in 27 patients (54%),
mosaic attenuation pattern in 18 patients (36%) and vascular
distortion in 10 patients (20%). Among the four types of
emphysema, centriacinar emphysema was observed most fre-
quently in 16 patients (32%), panacinar emphysema in 10
Table 4 Chest radiographic features in individual patients
(No. of patients 50).
Chest radiographic features No. of
patients
Percentage
of patients (%)
Low ﬂat diaphragm in P.A. view 2 4
Hyperinﬂated lungs in P.A. view 2 4
Attenuated peripheral blood
vessels in P.A. view
1 2
Tubular heart in P.A. view 2 4
Large retrosternal space in lateral view 3 6
Barrel chest in lateral view 3 6
All of above features in
P.A. and lateral views
7 14
Total 20 40
512 M.M.S. Mostafapatients (20%), distal acinar emphysema in 7 patients (14%).
All of above types of emphysema was presented in 17 patients
(34%). In our study, the emphysema was associated with
chronic bronchitis in 15 patients (30%).
The chest radiographic features in individual patients were
as shown in (Table 4). The posterior anterior view shows low
ﬂat diaphragm, hyperinﬂated lungs, attenuated peripheral
blood vessels and tubular heart. Lateral view shows large ret-
rosternal space and barrel chest. All those manifestations were
presented in 20 patients (40%) of all the cases. In addition all
these patients have been shown manifestations of emphysema
on HRCT.4. Discussion
Regarding patient sex all patients in our study are males. This
result was in agreement with Wang et al. (5) who found that
the prevalence of emphysema was higher in man than in wo-
men and that when present it was more severe among man.
Regarding pack years of cigarette smoking and the severity
of CT emphysema Mark et al. (6) found a distinct correlation
between smoking and the prevalence of emphysema, indexes of
smoke exposure did not correlate with the extent of CT abnor-
malities. Gillooly and Lamb (7) also reported no correlation
between smoking habits and the extent of microscopic
emphysema.
In our study, the correlation between HRCT and spirome-
try in the early diagnosis of the emphysema is considered mod-
erate. Nakano et al. (8) reported that an effort has been made
to correlate HRCT of emphysema as well as airway abnormal-
ities with spirometry that are moderate. Cerveri et al. (9)
showed that lung function tests are a better predictor of
emphysema as measured by HRCT scans explaining 71% of
the variability in its extent. Nakano et al. (10) and Fishman
et al. (11) mentioned emerging data that suggest that CT local-
ization of emphysema can be used to predict the response to
lung volume reduction surgery and to help select candidates
for the procedure. COPD Guidelines Group (12) also men-
tioned emphysema is a pathological diagnosis. The diagnosis
of emphysema during life is based on a combination of clinical,
functional and radiological ﬁndings, but this is a combination
that is insensitive to mild emphysema. The functional hall
mark of emphysema is decreased airﬂow at spirometry, but pa-
tients may have up to 30% of their lung involved with emphy-
sema and have no evidence of functional impairment. Gold (3)also mentioned that during the early stage of the COPD con-
ventional spirometry may reveal no abnormality as the earliest
changes affect the alveolar walls and small airways. Muller
(13) mentioned that emphysema can involve 30% of the lung
parenchyma without air ﬂow obstruction being present.
In our study, tracheal index <0.67% Case 5 was presented
in 27 patients (54%). Trigaux et al. (14) mentioned that saber
sheath trachea is a basically a sign of hyperinﬂation. Trigaux
et al. (15) also found that saber sheath trachea was established
as a speciﬁc radiographic diagnostic parameter in the diagnosis
of emphysema speciﬁcity (92.95), although the sensitivity
(39.1%) was low. I found saber sheath trachea in 27 patients,
sensitivity (54%). In our study, stern aortic distance 64 cm
was presented in 33 patients (66%). Hagen and Kolbenstvedt
(16) reported that stern aortic distance was measured in CT
sections at the carinal level if 4 cm or more is characteristic
for emphysema. In our study, the main vascular abnormalities
were seen to include vascular attenuation and distortion Case
6. Szilasi et al. (17) reported that the pulmonary arteries show
intimal thickening, smooth muscle hypertrophy and inﬂamma-
tion ﬁnally leading to vascular remodeling. Crofton and Doug-
las (18) also mentioned the vascular changes associated with
emphysema include, reduction in size and number of pulmon-
ary vessels particular at the peripheral third of lung zone,
vessel distortion producing increased branching angles,
excess straightening or bowing of vessels and areas of low
attenuation. Kalender (19) additionally noted attenuation
and pruning of the vascular tree and abnormal vascular conﬁg-
urations are seen in emphysema. Rosenkranz (20) also men-
tioned that the direct vascular changes and hyperinﬂation
lead to the pre-capillary type of pulmonary hypertension. In
our study, vascular distortion was presented in advanced cases
of the emphysema. Mac Nee et al. (21) mentioned that vascu-
lar distortion is present in very advanced cases of emphysema
and in those with severely deranged pulmonary functions. In
our study, mosaic attenuation pattern is present in only 18 pa-
tients (36%). Arakawa and Webb (22) mentioned that mosaic
attenuation is more pronounced on scans obtained at end expi-
ration compared to that found at end inspiration. This is the
probable reason for detection of mosaic attenuation pattern
in only 18 patients (36%). Copley et al. (23) mentioned that
mosaic attenuation pattern in association with other HRCT
features is observed to be helpful in distinguishing different
disease entities grouped under COPD. As regarding air way
abnormality, (Case 4) in our study, directly visible small air-
ways were observed as the most prevalent HRCT features of
38 patients (76%). Vignola et al. (24) reported that HRCT
has allowed the demonstration of several airway wall abnor-
malities, whose extent signiﬁcantly correlated with the clinical
severity of the disease. Tell et al. (25) mentioned that despite a
decreased radius of small airways, air ﬂow resistance is not sig-
niﬁcantly increased because of the large number of these
peripheral bronchioles. Hence not worth disease must be pres-
ent at the level of peripheral airways, to be detected on pul-
monary function tests. Here HRCT scan play an infallible
role in a diagnosis of involvement of small airways. Reilly
(26) mentioned that the HRCT has allowed for greater deﬁni-
tion of both parenchymal and airway abnormalities in emphy-
sema. In our study, all types of emphysema were presented in
17 patients (34%) among these the centriacinar emphysema
(Case 1) is the comments type of emphysema which was pre-
sented in 16 patients (32%) and is involved in the upper lobes.
Case 4 Axial HRCT image in patient with centriacinar emphy-
sema in the right upper lobe shows thickening of the bronchial
wall and mild narrowing of the lumen (arrow).
Case 3 Axial HRCT image in patient with centriacinar emphy-
sema in the right upper lobe shows emphysematous bulla at the
medial posterior aspect and small distal acinar emphysema at the
lateral aspect.
Case 1 Axial HRCT image in patient with centriacinar
emphysema in the upper lobe shows multiple round lucent areas
of various sizes surrounded by normal parenchyma.
Case 2 Axial HRCT image in patient with panacinar emphy-
sema in the upper lobe shows diffuse low attenuation the lung
ﬁeld.
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(4) who reported that centriacinar emphysema is the comments
type of pulmonary emphysema and with the Wright (27) who
mentioned that type is more common in the upper lung zones
of the upper and lower lobes. In our study, panacinar emphy-
sema (Case 2) was presented in 10 patients (20%) and is in-
volved in the lower lobes. Lamb (28) mentioned that this
type of emphysema is more prominent at the bases. Copley
et al. (29) also mentioned the same previous two results. In
our study, distal acinar emphysema Case 3 was presented in
7 patients (14%) and is involved the upper lobes and is the less
common type of emphysema. Thurlback (30) mentioned that
this type of emphysema is less common than centriacinar or
panacinar emphysema and is usually of little clinical signiﬁcant
except when it occurs extensively in subpleural position and
may be associated with pneumothorax. Lesur et al. (31) men-
tioned that this type of emphysema is usually limited in extent,
occurs most commonly along the dorsal surface of the upper
lung. In our study, bulbous emphysema (Case 3) is seen asso-
ciated with distal acinar and centriacinar emphysema. RichardWebb et al. (32) mentioned that bullae are most common with
distal acinar and centriacinar emphysema. Snider (33) CT al-
lows for an assessment not only of the extent of bulbous dis-
ease but also the degree of compression and the severity of
emphysema in the remaining lung parenchyma. As regarding
the last type of emphysema scare or irregular emphysema no
cases could be detected. In our study, the emphysema was
associated with chronic bronchitis in 15 patients (30%). Muller
and Thurlbeck (34) mentioned that partially the lack of close
Case 5 Axial HRCT image in patient with centriacinar emphy-
sema in the upper lobes show Saber sheath trachea sagittal and
coronal diameter of the trachea are illustrated. Tracheal param-
eters were sagittal diameter, 21.1 mm; coronal diameter, 12.2 mm;
tracheal index, 0.58.
Case 6 Axial HRCT image in patient with panacinar emphy-
sema shows vascular distortion characterized by increased branch-
ing angles and straightening of pulmonary vessels.
514 M.M.S. Mostafacorrelation between emphysema extent and airways obstruc-
tion reﬂects the fact that emphysema is often associated with
chronic bronchitis, which may also contribute to lung function
abnormalities in patients who have COPD and is more likely
responsible for airways obstruction. In a study by Gevenois
et al. (35) using inspiratory and expiratory HRCT, inspiratory
scans were found to be most accurate in showing the extent of
pathological emphysema, where as expiratory scans correlated
best with pulmonary function tests measures of airways
obstruction, fact which may be related to the presence of asso-
ciated airways disease. Richard Webb et al. (32) mentioned
that many patients who have emphysema also have chronic
bronchitis. In our study chest radiography detected emphy-
sema in 20 patients (40%) so its sensitivity was 40%. Because
our study was done for early diagnosis of emphysema chest
radiographs show low sensitivity in diagnosis since a positive
diagnosis depends on the severity of disease. Muller (13) men-
tioned that patients who have emphysema chest radiographyare normal in 20% or more of cases denoting less sensitivity.
Richard Webb (32) mentioned that standard chest radiogra-
phy and pulmonary function tests are insensitive for the early
diagnosis of emphysema. CT is undoubtedly more sensitive
than chest radiographs in diagnosis emphysema and in deter-
mining its type and extent. HRCT is also advantageous rela-
tive to conventional CT. If signiﬁcant emphysema is found
on HRCT, no further evaluation is necessary speciﬁcally, lung
biopsy is not needed. In a study by Klein et al. (36), the sensi-
tivity of chest radiography in the diagnosis of emphysema was
34%. Thurlbeck et al. (37) and COPD Guide Lines Group (12)
mentioned that mild emphysema is difﬁcult to detect on chest
radiography. In our study, the sensitivity of the spirometry in
early diagnosis of the emphysema was 80%. Hardie et al. (38)
mentioned that spirometry is used as a conﬁrmatory test as
well as a screening test for COPD, no gold standard exists
for comparison to provide precise estimation of sensitivity.
In our study, the sensitivity of the HRCT in early diagnosis
of the emphysema was 100%. Richard Webb et al. (32)
mentioned that in averaging the results of several studies, the
sensitivity of the HRCT for detecting emphysema is approxi-
mately 94%. Bonelli et al. (39) mentioned that in a retrospec-
tive review of HRCT ﬁndings in patients who had
pathologically proven cystic lung diseases including emphy-
sema the sensitivity of HRCT is 95% in the diagnosis of
emphysema. Webb (43) mentioned that HRCT has excellent
sensitivity in the diagnosis of COPD. Sanders et al. (40) men-
tioned that CT is a more sensitive measure of mild emphysema
than conventional lung function tests. Gurney et al. (41) stud-
ied 59 smokers and found that 40% of the patients had HRCT
evidence of emphysema but no functional evidence of emphy-
sema. This showed the sensitivity of HRCT for detecting
emphysema. Emphysema in the lower lobes had a better corre-
lation with abnormal pulmonary function tests than did
emphysema in the upper lobes. The authors pointed out that
upper lobe emphysema is relatively silent.
5. Conclusions
HRCT has much greater sensitivity than chest radiography
in early diagnosing of emphysema. HRCT is also capable
of differentiating between the various types of emphysema
and assessing its severity. The presence of emphysema can
be suspected on chest radiography but this is not a sensitive
technique for diagnosis. Also the chest radiography is not a
very good indicator for the severity of disease. In addition a
precise characterization of the emphysema by HRCT is
desirable for adequate therapy and monitoring as well as a
preoperative assessment of the patient before surgical treat-
ment of emphysema. Compared to spirometry, HRCT shows
the regional assessment of compartments involved (airways,
parenchyma and vasculature). Moreover spirometry has no
deﬁnite sensitivity.
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